Use of cholesterol-lowering therapy by elderly adults after myocardial infarction

被引:18
作者
Ayanian, JZ
Landrum, MB
McNeil, BJ
机构
[1] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Dept Med, Div Gen Med & Primary Care, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA
关键词
D O I
10.1001/archinte.162.9.1013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Use of cholesterol-lowering drugs reduces mortality and adverse cardiac events among people aged 65 to 75 years with coronary heart disease, but previous studies have shown that most patients have not received this treatment. Methods: We conducted a telephone survey during 1999 and 2000 of 815 Medicare beneficiaries aged 65 to 74 years hospitalized for an acute myocardial infarction in California, Florida, Massachusetts, New York, or Pennsylvania during 1994 and 1995. Outcome measures included use of cholesterol-lowering drugs, beliefs about the importance of lowering cholesterol levels, and knowledge of personal cholesterol levels, adjusting for demographic and clinical factors using logistic regression. Results: Among respondents, 59.4% reported taking a cholesterol-lowering drug, but most were not aware of potential adverse effects. In adjusted analyses, drug treatment was significantly more common among women, patients aged 65 to 69 years, and those who reported that a cardiologist was mainly responsible for their cholesterol management. Lowering cholesterol levels was viewed as "very important" by 77.2% of respondents, but significantly less often by men, older patients, and those with diabetes mellitus or congestive heart failure. Only 33.1% of respondents knew their cholesterol level, and this knowledge was significantly less common among black patients and those with diabetes mellitus or congestive heart failure. Conclusions: Use of cholesterol-lowering drugs was much greater than in previous studies of elderly patients after myocardial infarction, demonstrating increased attention to secondary prevention. However, most patients were unaware of their cholesterol level or potential adverse effects of drug treatment, indicating that they may benefit from greater education about cholesterol testing and treatment.
引用
收藏
页码:1013 / 1019
页数:7
相关论文
共 31 条
[2]   DIFFERENCES IN THE USE OF PROCEDURES BETWEEN WOMEN AND MEN HOSPITALIZED FOR CORONARY HEART-DISEASE [J].
AYANIAN, JZ ;
EPSTEIN, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (04) :221-225
[3]   Observations of the treatment of women in the United States with myocardial infarction - A report from the National Registry of Myocardial Infarction-I [J].
Chandra, NC ;
Ziegelstein, RC ;
Rogers, WJ ;
Tiefenbrunn, AJ ;
Gore, JM ;
French, WJ ;
Rubison, M .
ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (09) :981-988
[4]   The National Cholesterol Education Program - Progress and prospects [J].
Cleeman, JI ;
Lenfant, C .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (24) :2099-2104
[5]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[6]   QUALITY OF CARE FOR MEDICARE PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION - A 4-STATE PILOT-STUDY FROM THE COOPERATIVE CARDIOVASCULAR PROJECT [J].
ELLERBECK, EF ;
JENCKS, SF ;
RADFORD, MJ ;
KRESOWIK, TF ;
CRAIG, AS ;
GOLD, JA ;
KRUMHOLZ, HM ;
VOGEL, RA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (19) :1509-1514
[7]   Treatment of acute myocardial infarction and 30-day mortality among women and men. [J].
Gan, SC ;
Beaver, SK ;
Houck, PM ;
MacLehose, RF ;
Lawson, HW ;
Chan, L .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (01) :8-15
[8]   Cholesterol lowering in the elderly population [J].
Grundy, SM ;
Cleeman, JI ;
Rifkind, BM ;
Kuller, LH .
ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (15) :1670-1678
[9]   Appropriateness of coronary angiography after myocardial infarction among medicare beneficiaries: Managed care versus fee for service. [J].
Guadagnoli, E ;
Landrum, MB ;
Peterson, EA ;
Gahart, MT ;
Ryan, TJ ;
McNeil, BJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (20) :1460-1466
[10]   Benefits of pravastatin on cardiovascular events and mortality in older patients with coronary heart disease are equal to or exceed those seen in younger patients: Results from the LIPID trial [J].
Hunt, D ;
Young, P ;
Simes, J ;
Hague, W ;
Mann, S ;
Owensby, D ;
Lane, G ;
Tonkin, A .
ANNALS OF INTERNAL MEDICINE, 2001, 134 (10) :931-940